CoChat

Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective

Open access
Hampel, Harald, Lista, Simone, Mango, Dalila, Nisticò, Robert, Perry, George, Avila, Jesus, Hernandez, Felix, Geerts, Hugo, Vergallo, Andrea, Alzheimer Precision Medicine Initiative (APMI), AFSHAR, Mohammad, AGUILAR, Lisi Flores, AKMAN-ANDERSON, Leyla, ARENAS, Joaquín, AVILA, Jesus, BABILONI, Claudio, BALDACCI, Filippo, BATRLA, Richard, BENDA, Norbert, BLACK, Keith L., BOKDE, Arun L.W., BONUCCELLI, Ubaldo, BROICH, Karl, CACCIOLA, Francesco, CARACI, Filippo, CASTRILLO, Juan, CAVEDO, Enrica, CERAVOLO, Roberto, CHIESA, Patrizia A., CORVOL, Jean-Christophe, CUELLO, Augusto Claudio, CUMMINGS, Jeffrey L., DEPYPERE, Herman, DUBOIS, Bruno, DUGGENTO, Andrea, EMANUELE, Enzo, ESCOTT-PRICE, Valentina, FEDEROFF, Howard, FERRETTI, Maria Teresa, FIANDACA, Massimo, FRANK, Richard A., GARACI, Francesco, GEERTS, Hugo, GIORGI, Filippo S., GOETZL, Edward J., GRAZIANI, Manuela, HABERKAMP, Marion, HABERT, Marie-Odile, HAMPEL, Harald, HERHOLZ, Karl, HERNANDEZ, Felix, KAPOGIANNIS, Dimitrios, KARRAN, Eric, KIDDLE, Steven J., KIM, Seung H., KORONYO, Yosef, KORONYO-HAMAOUI, Maya, LANGEVIN, Todd, LEHÉRICY, Stéphane, LUCÍA, Alejandro, LISTA, Simone, LORENCEAU, Jean, MANGO, Dalila, MAPSTONE, Mark, NERI, Christian, NISTICÓ, Robert, O’BRYANT, Sid E., PALERMO, Giovanni, PERRY, George, RITCHIE, Craig, ROSSI, Simone, SAIDI, Amira, SANTARNECCHI, Emiliano, SCHNEIDER, Lon S., SPORNS, Olaf, TOSCHI, Nicola, VERDOONER, Steven R., VERGALLO, Andrea, VILLAIN, Nicolas, WELIKOVITCH, Lindsay A., WOODCOCK, Janet, YOUNESI, Erfan · 2019 · Journal of Alzheimer’s Disease
Cited by 65

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Systems pharmacology is a novel framework for drug research that models traditional and innovative pharmacological parameters and provides the overall efficacy and safety profile of a drug across body systems and complex, non-linear, molecular interactions. Lithium chloride, a pharmacological compound approved for the therapy of psychiatric disorders, represents a poorly explored compound for the treatment of Alzheimer’s disease (AD). Lithium has been shown to reduce downstream effects associated with the aberrant overactivation of certain molecular pathways, such as glycogen synthase kinase 3 subunit β (GSK3-β)-related pathways, involved in AD-related pathophysiology. It seems that overactivation and overexpression of GSK3-β lead to an impairment of long-term potentiation and amyloid-β induced neurotoxicity that can be normalized using lithium. Moreover, a growing body of evidence has demonstrated that lithium’s GSK3-β inhibitory effect prevents tau phosphorylation in mouse models of tauopathies. Clinical data have been inconclusive, partly due to methodological limitations. The lack of studies exploring the dynamics of protein misfolding in AD and investigating the specific tau-isoforms appearing prior to the accumulation of neurofibrillary tangles calls for new and optimized clinical trials. Advanced computer modeling based on a formal implementation of quantitative parameters and basic enzymatic insights into a mechanism-based model would present a good start to tackle these non-linear interactions. This innovative approach will pave the way for developing “molecularly” biomarker-guided targeted therapies, i.e., treatments specifically adapted (“tailored”) to the individual, consistently with the primary objectives and key conceptual points of precision medicine and precision pharmacology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-190197

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

Metadata

Authors
Hampel, H., Lista, S., Mango, D., Nisticò, R., Perry, G., Avila, J., Hernandez, F., Geerts, H., Vergallo, A., (APMI), A. P. M. I., AFSHAR, M., AGUILAR, L. F., AKMAN-ANDERSON, L., ARENAS, J., AVILA, J., BABILONI, C., BALDACCI, F., BATRLA, R., BENDA, N., BLACK, K. L., BOKDE, A. L. W., BONUCCELLI, U., BROICH, K., CACCIOLA, F., CARACI, F., CASTRILLO, J., CAVEDO, E., CERAVOLO, R., CHIESA, P. A., CORVOL, J.-C., CUELLO, A. C., CUMMINGS, J. L., DEPYPERE, H., DUBOIS, B., DUGGENTO, A., EMANUELE, E., ESCOTT-PRICE, V., FEDEROFF, H., FERRETTI, M. T., FIANDACA, M., FRANK, R. A., GARACI, F., GEERTS, H., GIORGI, F. S., GOETZL, E. J., GRAZIANI, M., HABERKAMP, M., HABERT, M.-O., HAMPEL, H., HERHOLZ, K., HERNANDEZ, F., KAPOGIANNIS, D., KARRAN, E., KIDDLE, S. J., KIM, S. H., KORONYO, Y., KORONYO-HAMAOUI, M., LANGEVIN, T., LEHÉRICY, S., LUCÍA, A., LISTA, S., LORENCEAU, J., MANGO, D., MAPSTONE, M., NERI, C., NISTICÓ, R., O’BRYANT, S. E., PALERMO, G., PERRY, G., RITCHIE, C., ROSSI, S., SAIDI, A., SANTARNECCHI, E., SCHNEIDER, L. S., SPORNS, O., TOSCHI, N., VERDOONER, S. R., VERGALLO, A., VILLAIN, N., WELIKOVITCH, L. A., WOODCOCK, J., & YOUNESI, E.
Venue
Journal of Alzheimer’s Disease
Published
2019-06-04
Volume
69
Issue
3
Pages
615-629
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2947789569
Cited by
65
References
29
FWCI
5.43
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.